Pharmacokinetics of tenofovir during pregnancy and postpartum

Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study

(2013) Ying Cao et al.   BMC INFECTIOUS DISEASES

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

(2012) Angela P.H. Colbers et al.   AIDS

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

(2012) Kajal Buckoreelall et al.   CLINICAL PHARMACOKINETICS

Comparison of Bone and Renal Effects In HIV-infected Adults Switching to Abacavir or Tenofovir Based Therapy in a Randomized Trial

(2012) Thomas A. Rasmussen et al.   PLoS One

Plasma and Intracellular Tenofovir Pharmacokinetics in the Neonate (ANRS 12109 Trial, Step 2)

(2011) Déborah Hirt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pregnancy-Related Effects on Tenofovir Pharmacokinetics: a Population Study with 186 Women

(2011) Sihem Benaboud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

(2011) Patricia M. Flynn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards

(2009) Tom Delahunty et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)

(2008) D Hirt et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS